Cysal
Latest round
- Seed
Last raised
- Nov 2012
Total raised
- Undisclosed
Investors
- 2
About Cysal
Founded in 2012 in Munster, Germany, Cysal GmbH operates within the biotechnology sector, providing specialized fermentation technologies. The company has not undergone significant pivots or changes in its business strategy since its inception. It was established by a group of individuals with expertise in the field, though specific founder details are not available.Cysal GmbH specializes in advanced biotechnological fermentation strategies that replace traditional chemical methods for producing specialty and base commodities. Their core offerings include the optimization and selection of microbial strains tailored for the production of new compounds and activities, alongside the development of complete fermentation and downstream technologies scalable to industrial levels. Cysal’s services cater to various sectors, specifically targeting biotechnology companies, including science-to-business startups, by providing flexible and affordable solutions for developing novel industrial fermentation technologies. These innovations are designed to address increasing market demands for sustainable alternatives in cosmetics, food, and feed applications.Cysal GmbH generates revenue through a variety of business transaction structures primarily involving partnerships, consultancy services, and project-based contracts. The company engages in direct collaborations with biotechnology firms and startups, offering hands-on support in areas such as intellectual property, feasibility studies, and regulatory affairs. This business model typically includes project fees for the development of tailored fermentation processes and microbial strain optimizations, allowing clients to scale their production efficiently. Cysal's revenue streams are further bolstered through licensing agreements, particularly involving patented technologies related to functional ingredients.Cysal GmbH is focused on expanding its product offerings and market presence. The company aims to design and launch new fermentation technologies targeting the cosmetics and food sectors by 2024. Plans are in place to expand into North American markets, particularly the United States, by 2025.
Who invested in Cysal
2 investors across 1 round
See all investors in Cysal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 8, 2012
Amount
Undisclosed
Investors
Questions about Cysal
Who invested in Cysal?
Cysal has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cysal raised?
Cysal has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cysal last raise money?
Cysal's most recent round on record is a Seed, in Nov 2012.
What does Cysal do?
Founded in 2012 in Munster, Germany, Cysal GmbH operates within the biotechnology sector, providing specialized fermentation technologies.
Where is Cysal headquartered?
Cysal is headquartered in Munster, Germany.
Which VCs invest in companies like Cysal?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Cysal's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cysal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.